10-87933145-G-T
Variant summary
Our verdict is Pathogenic. Variant got 17 ACMG points: 17P and 0B. PM1PM2PM5PP2PP3_ModeratePP5_Very_Strong
The NM_000314.8(PTEN):c.386G>T(p.Gly129Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/23 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G129E) has been classified as Pathogenic.
Frequency
Consequence
NM_000314.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 17 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PTEN | NM_000314.8 | c.386G>T | p.Gly129Val | missense_variant | Exon 5 of 9 | ENST00000371953.8 | NP_000305.3 | |
PTEN | NM_001304717.5 | c.905G>T | p.Gly302Val | missense_variant | Exon 6 of 10 | NP_001291646.4 | ||
PTEN | NM_001304718.2 | c.-365G>T | 5_prime_UTR_variant | Exon 4 of 9 | NP_001291647.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Cowden syndrome 1 Pathogenic:1
This variant is considered likely pathogenic. This variant is expected to disrupt protein structure [Myriad internal data]. This variant has been reported in multiple individuals with clinical features of gene-specific disease [PMID: 21659347, 30327747]. -
PTEN hamartoma tumor syndrome Pathogenic:1
This variant is not present in population databases (ExAC no frequency). This variant has been observed in individual(s) with clinical features of PTEN hamartoma tumor syndrome (PMID: 30327747, 21659347, external communication). In at least one individual the variant was observed to be de novo. This variant has been reported to affect PTEN protein function (PMID: 21828076). This sequence change replaces glycine with valine at codon 129 of the PTEN protein (p.Gly129Val). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and valine. For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Gly129 amino acid residue in PTEN. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 22469695, 9256433, 28497778, 17928923, 25527629, 9140396, 21659347, 23399955, 10051603). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. -
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.G129V pathogenic mutation (also known as c.386G>T), located in coding exon 5 of the PTEN gene, results from a G to T substitution at nucleotide position 386. The glycine at codon 129 is replaced by valine, an amino acid with dissimilar properties. This alteration has been reported in the literature in 1 of 802 patients referred for PTEN analysis (Pilarski R et al. J. Med. Genet. 2011 Aug; 48(8):505-12). Further, an in vivo functional analysis of this alteration using a heterologous yeast reconstitution system revealed that this alteration gives rise to an inactive protein (Rodríguez-Escudero I et al. Hum. Mol. Genet. 2011 Nov;20(21):4132-42). An alteration at the same codon, p.G129E (c.386G>A), has been well described in the literature as a pathogenic mutation, having been observed in multiple Cowden disease cohorts (Liaw D et al. Nat. Genet. 1997 May;16(1):64-7; Pilarski R et al. J. Med. Genet. 2011 Aug;48(8):505-12). Based on the available evidence, this variant is classified as a pathogenic mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at